| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study
|
Brooks, Jennifer D.
|
|
|
54 |
C |
p. 62-69
|
artikel
|
| 2 |
Accelerated partial breast irradiation with 3-dimensional conformal and image-guided intensity-modulated radiotherapy following breast conserving surgery – 7-Year results of a phase II trial
|
Mészáros, Norbert
|
|
|
54 |
C |
p. 222-228
|
artikel
|
| 3 |
Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis
|
Gao, Hong-Fei
|
|
|
54 |
C |
p. 79-87
|
artikel
|
| 4 |
A nationwide, multicenter retrospective study on the effectiveness and safety of eribulin in Korean breast cancer patients (REMARK)
|
Park, Min Ho
|
|
|
54 |
C |
p. 121-126
|
artikel
|
| 5 |
A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting
|
Clemons, M.
|
|
|
54 |
C |
p. 278-285
|
artikel
|
| 6 |
Breast cancer survival in Brazil: How much health care access impact on cancer outcomes?
|
Caleffi, Maira
|
|
|
54 |
C |
p. 155-159
|
artikel
|
| 7 |
Breast-conserving surgery with or without irradiation in women with invasive ductal carcinoma of the breast receiving preoperative systemic therapy: A cohort study
|
Zhang, Jiaqiang
|
|
|
54 |
C |
p. 139-147
|
artikel
|
| 8 |
Breast ultrasound in breast cancer surveillance; incremental cancers found at what cost?
|
Bromley, Luke
|
|
|
54 |
C |
p. 272-277
|
artikel
|
| 9 |
Calorie restriction and synbiotics effect on quality of life and edema reduction in breast cancer-related lymphedema, a clinical trial
|
Vafa, Saeideh
|
|
|
54 |
C |
p. 37-45
|
artikel
|
| 10 |
Chemotherapy and 21-gene recurrence score testing for older breast cancer patients: A competing-risks analysis
|
Zhou, Ping
|
|
|
54 |
C |
p. 319-327
|
artikel
|
| 11 |
Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis
|
Han, Yiqun
|
|
|
54 |
C |
p. 114-120
|
artikel
|
| 12 |
Clinicopathological features of breast cancer without mammographic findings suggesting malignancy
|
Nakamura, Mei
|
|
|
54 |
C |
p. 335-342
|
artikel
|
| 13 |
Complete response of leptomeningeal carcinomatosis secondary to breast cancer
|
Troussier, Idriss
|
|
|
54 |
C |
p. 328-330
|
artikel
|
| 14 |
Correlation of size and focality with prognosis in small breast carcinoma: a single institution case series
|
Mastropasqua, Mauro G.
|
|
|
54 |
C |
p. 164-169
|
artikel
|
| 15 |
Differences in breast cancer risk after benign breast disease by type of screening diagnosis
|
Louro, Javier
|
|
|
54 |
C |
p. 343-348
|
artikel
|
| 16 |
Digital analysis of distant and cancer-associated mammary adipocytes
|
Isnaldi, Edoardo
|
|
|
54 |
C |
p. 179-186
|
artikel
|
| 17 |
Do all patients with HER2 positive breast cancer require one year of adjuvant trastuzumab? A systematic review and meta-analysis
|
Stewart, Paul
|
|
|
54 |
C |
p. 203-210
|
artikel
|
| 18 |
Editorial Board
|
|
|
|
54 |
C |
p. i
|
artikel
|
| 19 |
Effect of pathologic stages on postmastectomy radiation therapy in breast cancer receiving neoadjuvant chemotherapy and total mastectomy: A Cancer Database Analysis
|
Zhang, Jiaqiang
|
|
|
54 |
C |
p. 70-78
|
artikel
|
| 20 |
Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data
|
Choi, Sung Hyouk
|
|
|
54 |
C |
p. 25-30
|
artikel
|
| 21 |
Effects of the COVID-19 pandemic on breast cancer screening in Taiwan
|
Tsai, Huei-Yi
|
|
|
54 |
C |
p. 52-55
|
artikel
|
| 22 |
Eligibility of real-world patients with metastatic breast cancer for clinical trials
|
Batra, Atul
|
|
|
54 |
C |
p. 171-178
|
artikel
|
| 23 |
Epidemiology of male breast cancer
|
Konduri, Santhi
|
|
|
54 |
C |
p. 8-14
|
artikel
|
| 24 |
First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study
|
Hardy-Bessard, Anne-Claire
|
|
|
54 |
C |
p. 256-263
|
artikel
|
| 25 |
Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study
|
Batra, Atul
|
|
|
54 |
C |
p. 1-7
|
artikel
|
| 26 |
HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab
|
Li, Shuai
|
|
|
54 |
C |
p. 235-241
|
artikel
|
| 27 |
Immediate Breast Reconstruction after mastectomy with polyurethane implants versus textured implants: A retrospective study with focus on capsular contracture
|
Loreti, Andrea
|
|
|
54 |
C |
p. 127-132
|
artikel
|
| 28 |
Individualized-thresholding Shear Wave Elastography combined with clinical factors improves specificity in discriminating breast masses
|
Gu, Juanjuan
|
|
|
54 |
C |
p. 248-255
|
artikel
|
| 29 |
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany
|
Schneeweiss, Andreas
|
|
|
54 |
C |
p. 88-95
|
artikel
|
| 30 |
Intrinsic subtype distribution should vary according to institutions
|
Horimoto, Yoshiya
|
|
|
54 |
C |
p. 349
|
artikel
|
| 31 |
Neoadjuvant chemotherapy and HER2 dual blockade including biosimilar trastuzumab (SB3) for HER2-positive early breast cancer: Population based real world data from the Danish Breast Cancer Group (DBCG)
|
Berg, Tobias
|
|
|
54 |
C |
p. 242-247
|
artikel
|
| 32 |
NT-proBNP as predictor factor of cardiotoxicity during trastuzumab treatment in breast cancer patients
|
Blancas, Isabel
|
|
|
54 |
C |
p. 106-113
|
artikel
|
| 33 |
Occult breast cancer: Where are we at?
|
Ofri, Adam
|
|
|
54 |
C |
p. 211-215
|
artikel
|
| 34 |
Older women’s experience with breast cancer treatment: A systematic review of qualitative literature
|
Angarita, Fernando A.
|
|
|
54 |
C |
p. 293-302
|
artikel
|
| 35 |
Orthotopic grafting of decellularized human nipple: Setting the stage and putative mechanism of healing
|
Johnson, Peter C.
|
|
|
54 |
C |
p. 96-98
|
artikel
|
| 36 |
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
|
Manso, Luis
|
|
|
54 |
C |
p. 286-292
|
artikel
|
| 37 |
Participation in breast cancer screening among breast cancer survivors –A nationwide register-based cohort study
|
Larsen, Mette Bach
|
|
|
54 |
C |
p. 31-36
|
artikel
|
| 38 |
Pathologic response at the epicenter of the treatment decision-making process in Human Epidermal Receptor–Type 2 overexpressing (Her2+) Early Breast Cancer (EBC): Challenges and opportunities for financially-constrained healthcare systems
|
Mano, Max S.
|
|
|
54 |
C |
p. 331-334
|
artikel
|
| 39 |
Prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies
|
Chen, Ying
|
|
|
54 |
C |
p. 264-271
|
artikel
|
| 40 |
Prognosis of HER2-positive pregnancy-associated breast cancer: Analysis from the French CALG (Cancer Associé à La Grossesse) network
|
Boudy, Anne-Sophie
|
|
|
54 |
C |
p. 311-318
|
artikel
|
| 41 |
Quality indicators for the diagnosis and surgical management of breast cancer in South Africa
|
Nietz, Sarah
|
|
|
54 |
C |
p. 187-196
|
artikel
|
| 42 |
Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer
|
Porte, B.
|
|
|
54 |
C |
p. 303-310
|
artikel
|
| 43 |
Response to: Intrinsic subtype distribution should vary according to institutions
|
Fischer Maranta, Angela
|
|
|
54 |
C |
p. 350
|
artikel
|
| 44 |
Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study
|
Fasching, Peter A.
|
|
|
54 |
C |
p. 148-154
|
artikel
|
| 45 |
Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia
|
Fuentes-Antrás, Jesús
|
|
|
54 |
C |
p. 160-163
|
artikel
|
| 46 |
Self-reported symptoms among participants in a population-based screening program
|
Larsen, Marthe
|
|
|
54 |
C |
p. 56-61
|
artikel
|
| 47 |
Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio
|
Lee, Clara Inkyung
|
|
|
54 |
C |
p. 229-234
|
artikel
|
| 48 |
Symptoms in long-term breast cancer survivors: A cross-sectional study in primary care
|
Maass, S.W.M.C.
|
|
|
54 |
C |
p. 133-138
|
artikel
|
| 49 |
Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial
|
Hale, Michael J.
|
|
|
54 |
C |
p. 216-221
|
artikel
|
| 50 |
The impact on clinical outcomes of post-operative radiation therapy delay after neoadjuvant chemotherapy in patients with breast cancer: A multicentric international study
|
Marta, Gustavo Nader
|
|
|
54 |
C |
p. 46-51
|
artikel
|
| 51 |
The use of 18F-FDG positron emission tomography to detect mediastinal lymph nodes in metastatic breast cancer
|
Onal, Cem
|
|
|
54 |
C |
p. 197-202
|
artikel
|
| 52 |
Upama – Analogies in Ayurveda
|
Rashmi, T.M.
|
|
|
54 |
C |
p. 170
|
artikel
|
| 53 |
Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study
|
Nickel, Brooke
|
|
|
54 |
C |
p. 99-105
|
artikel
|
| 54 |
Which clinical, radiological, histological, and molecular parameters are associated with the absence of enhancement of known breast cancers with Contrast Enhanced Digital Mammography (CEDM)?
|
Bicchierai, Giulia
|
|
|
54 |
C |
p. 15-24
|
artikel
|
Tijdschrift beschrijving